Oxford Nanopore Technologies
Oxford Nanopore Technologies, a pioneering company in the field of genomics, is headquartered in the United Kingdom. Founded in 2005, the company has rapidly established itself as a leader in the biotechnology industry, focusing on innovative DNA and RNA sequencing technologies. With a commitment to making genomic information accessible, Oxford Nanopore offers unique products such as the MinION, a portable sequencer that enables real-time analysis of genetic material. This groundbreaking technology distinguishes itself through its scalability and versatility, catering to a wide range of applications from academic research to clinical diagnostics. Recognised for its significant contributions to the field, Oxford Nanopore has achieved notable milestones, including the first real-time sequencing of a human genome. The company continues to expand its global presence, driving advancements in genomics and empowering researchers worldwide.
DitchCarbon Score
How does Oxford Nanopore Technologies's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Furniture Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Oxford Nanopore Technologies's score of 59 is higher than 99% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Oxford Nanopore Technologies's reported carbon emissions
In 2023, Oxford Nanopore Technologies reported total greenhouse gas emissions of approximately 15,580,000 kg CO2e, comprising 361,000 kg CO2e from Scope 1, 1,197,000 kg CO2e from Scope 2, and about 51,704,000 kg CO2e from Scope 3 emissions. This reflects a significant commitment to sustainability, as the company has set ambitious targets to address its carbon footprint. Oxford Nanopore Technologies aims to achieve net-zero greenhouse gas emissions across its entire value chain by 2045. In the near term, the company has committed to reducing absolute Scope 1 and 2 emissions by 42% by 2030, using 2023 as the baseline year. Additionally, it plans to reduce Scope 3 emissions by 52% per GBP value added within the same timeframe. Long-term, the company targets a 90% reduction in absolute emissions across all scopes by 2045. These commitments align with industry standards for climate action, demonstrating Oxford Nanopore Technologies's dedication to mitigating climate change and promoting sustainability within the pharmaceuticals, biotechnology, and life sciences sector.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|
| Scope 1 | 14,800 | 0,000 | 000,000 | 000,000 | 000,000 | 000,000 |
| Scope 2 | 126,000 | 000,000 | 0,000,000 | 0,000,000 | 000,000 | 0,000,000 |
| Scope 3 | 768,000 | 000,000 | 00,000 | 00,000 | 00,000,000 | 00,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Oxford Nanopore Technologies is committed to some reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
